Table 4.
Death (n=10) | Survival (n=28) | p value | HR | 95% CI | p value | |
---|---|---|---|---|---|---|
Cancer | 5 (50%) | 2 (7%) | 0.027 | |||
Chronic liver disease | 5 (50%) | 5 (18%) | 0.010 | |||
Healthcare-associated IE | 3 (30%) | 1 (4%) | 0.019 | |||
EuroSCORE II1 ≥9% | 5 (50%) | 6 (21%) | 0.087 | 173.60 | 6.74-4475.27 | 0.002 |
Charlson Comorbidity Index1 | 7.6±2.5 | 4.7±2.7 | 0.004 | 1.57 | 1.06-2.31 | 0.023 |
Katz Index1 | 1.0±1.9 | 3.4±2.7 | 0.015 | |||
SOFA score1 | 8.4±3.2 | 6.5±2.5 | 0.060 | |||
Staphylococcus . aureus etiology | 6 (60%) | 6 (21%) | 0.024 | 9.31 | 1.86-46.70 | 0.007 |
Vegetation presentation | 10 (100%) | 21 (75%) | 0.080 | |||
Early surgery | 2 (20%) | 20 (71%) | 0.005 | 0.04 | 0.002-0.80 | 0.035 |
1at the time of establishing the diagnosis.
HR: hazard ratio, CI: confidence interval, IE: infective endocarditis, SOFA: sequential organ failure assessment